These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 29604392)
21. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness. Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592 [TBL] [Abstract][Full Text] [Related]
22. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells. Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma. Zhang H; Shi X; Chang W; Li Y; Wang L; Wang L Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103 [TBL] [Abstract][Full Text] [Related]
24. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma. Islam F; Gopalan V; Lam AK Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178 [TBL] [Abstract][Full Text] [Related]
25. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma. Xu F; Liu Z; Liu R; Lu C; Wang L; Mao W; Zhu Q; Shou H; Zhang K; Li Y; Chu Y; Gu J; Ge D Cell Commun Signal; 2020 Feb; 18(1):17. PubMed ID: 32014008 [TBL] [Abstract][Full Text] [Related]
26. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma. Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860 [TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway. Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741 [TBL] [Abstract][Full Text] [Related]
28. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma. Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401 [TBL] [Abstract][Full Text] [Related]
29. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways. Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944 [TBL] [Abstract][Full Text] [Related]
30. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680 [TBL] [Abstract][Full Text] [Related]
31. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma. Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102 [TBL] [Abstract][Full Text] [Related]
32. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis. Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression. Gao T; He B; Pan Y; Xu Y; Li R; Deng Q; Sun H; Wang S Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416 [TBL] [Abstract][Full Text] [Related]
34. The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma. Zhang HF; Wu C; Alshareef A; Gupta N; Zhao Q; Xu XE; Jiao JW; Li EM; Xu LY; Lai R Stem Cells; 2016 Aug; 34(8):2040-51. PubMed ID: 27144349 [TBL] [Abstract][Full Text] [Related]
35. miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. Yu X; Jiang X; Li H; Guo L; Jiang W; Lu SH Stem Cells Dev; 2014 Mar; 23(6):576-85. PubMed ID: 24219349 [TBL] [Abstract][Full Text] [Related]
36. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line. Kim D; Park M; Jang H; Hyun H; Lim W Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217 [TBL] [Abstract][Full Text] [Related]
37. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma. Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090 [TBL] [Abstract][Full Text] [Related]
38. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells. Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489 [TBL] [Abstract][Full Text] [Related]
39. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Ma S; Lee TK; Zheng BJ; Chan KW; Guan XY Oncogene; 2008 Mar; 27(12):1749-58. PubMed ID: 17891174 [TBL] [Abstract][Full Text] [Related]
40. Nano Let‑7b sensitization of eliminating esophageal cancer stem‑like cells is dependent on blockade of Wnt activation of symmetric division. Pang Y; Liu J; Li X; Zhang Y; Zhang B; Zhang J; Du N; Xu C; Liang R; Ren H; Tang SC; Sun X Int J Oncol; 2017 Oct; 51(4):1077-1088. PubMed ID: 28902370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]